This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cimminiello, C. Articles by Bonfardeci, G. Search for Related Content PubMed PubMed Citation Articles by Cimminiello, C. Articles by Bonfardeci, G. Social Bookmarking                   What's this?

Plasma Levels of Tumor Necrosis Factor and Endothelial Response in Patients with Chronic Arterial Obstructive Disease or Raynaud's Phenomenon

Fourth Internal Medicine Department, Vascular and Thrombotic Pathology

Guido Arpaia, M.D.

Fourth Internal Medicine Department, Vascular and Thrombotic Pathology

Vincenzo Toschi, M.D.

Immunohematology Center, S. Carlo Borromeo General Hospital, Milan, Italy

Florica Rossi, M.D.

Fourth Internal Medicine Department, Vascular and Thrombotic Pathology

Manuela Aloisio, M.D.

Fourth Internal Medicine Department, Vascular and Thrombotic Pathology

Adele Motta

Fourth Internal Medicine Department, Vascular and Thrombotic Pathology

Giuseppe Bonfardeci, M.D.

Fourth Internal Medicine Department, Vascular and Thrombotic Pathology

Tumor necrosis factor alpha (TNF-alpha) is a cytokine that affects endothelial cells' function by changing their antithrombotic potential to a net procoagulant effect. Only a few data have so far been reported for the pathophysiologic role of TNF in vascular diseases in the involvement of microvessels and/or macrovessels and a prothrombotic state. In the present study the authors evaluated plasma TNF (and interleukin-1) levels in 20 patients with chronic arterial obstructive disease (CAOD) with intermittent claudi cation and 10 CAOD patients with more severe disease (pain at rest/skin ulcers). In addition, they studied 10 patients with Raynaud's phenomenon (RP), suspected to be secondary to a collagen disease. The control group consisted of 20 subjects matched for sex and age with the three groups of patients. TNF levels were assayed by enzyme-linked immunosorbent assay

The antigen levels of von Willebrand factor (vWF), tissue plasminogen activator (t- PA), and its inhibitor (PAI) were also determined as markers of release from the endothe lium, while the fragment 1+2 of prothrombin (F1+2) and thrombin-antithrombin III (TAT) complexes were assessed as indexes of systemic thrombin generation.

TNF levels were significantly higher in both groups of CAOD patients than in controls or RP patients, and the same was true for vWF. t-PA was significantly higher only in the CAOD subjects with more severe disease. No differences among groups were seen in PAI antigen/activity or thrombin generation. When data were corrected for age, TNF no longer differentiated CAOD patients from controls and RP subjects. There were strong direct correlations between TNF and age (r=0.57, P=0.0001); TNF and t-PA (r=0.43, P=0.002); and TNF and vWF (r=0.52, P=0.0001). The association of TNF with vWF was indepen dent of other variables. The present study suggests that TNF plays an important role in the pathophysiology of arterial diseases of atherosclerotic origin, especially during aging.

Angiology, Vol. 45, No. 12, 1015-1022 (1994)
DOI: 10.1177/000331979404501204


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?